
A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

